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Polymerase chain reaction and focal contact formation indicate integrin
expression in mesangial cells. Cultured kidney glomerular mesangial
cells (MCs) allow the role of extracellular matrix (ECM) and growth
factors in glomerular inflammatory disease to be studied. To investigate
the potential of MCs to interact with matrix components, the expression
of integrin mRNA in cultured MCs was examined by polymerase chain
reaction (PCR), by Northern blotting and by immunofluorescence. In
addition, the effect of matrix substrates on mRNA expression was
assessed by PCR. Northern blots with cDNA probes to integnn
a-chains revealed that MCs expressed al, a3 and aS integrin mRNA.
al and a3 were the major messages. No a2, a4 or a6 were detectable.
RT-PCR revealed that a2 and a6 were also expressed at low levels. The
control cells, HTIO8O, expressed a2, a3, a4, a5 and a6 mRNA, and
Rugli expressed al, a3, and a5, supporting previous studies. Immuno-
cytochemistry confirmed that alf3l, a2/3l, a3/31 and a5l integrins
were expressed and that they were concentrated into focal adhesions
(alf3l on type I collagen and laminin; a2f3l on type I collagen; a3f31 on
type I collagen, laminin and fibronectin; a5/31 on fibronectin). a6131 was
not detected in focal contacts. Attachment, spreading, and formation of
talin and integrin containing focal contacts still occurred when endog-
enous protein synthesis was blocked with 30 ml' cycloheximide.
Variation of substrate did not lead to a rapid degradation of integrin
a-chain mRNA as assessed by RT-PCR. These results provide a basis
for studying the regulation of interactions between MCs and extracel-
lular matrix mediated by integrins.
Regulated cell interaction with the extracellular matrix oc-
curs in diverse processes of tissue development and remodel-
ing; failure of the regulation characterizes many pathological
conditions. Matrix components can influence cell attachment,
motion, differentiation and proliferation, and resemble solid
phase analogues of the soluble growth factors [1]. In recent
years it has become apparent that the integrins are a major class
of cell-surface receptors involved in cell-matrix interactions.
The smooth muscle-like cells of the glomerular mesangium
are embedded in and interact with a basement membrane-like
extracellular matrix. This interaction contributes to the perme-
ability of the glomerulus, both in regulation of fluid flow through
the glomerular capillary tuft, and restriction of access fo
invading leukocytes [2, 3]. The mesangial matrix contains
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collagen type IV, laminin, fibronectin and various proteogly-
cans [4, 5]. In the chronic glomerular diseases that lead to
glomerulosclerosis, inflammatory processes induce changes in
the matrix and the proliferation of the mesangial cells [4—6].
These events contribute to scarring, blocking of the glomerular
capillary tuft and kidney failure. Extracellular matrix can mod-
ulate cell behavior, however, little is known about mesangial
cell (MC) interactions with matrix molecules. 131-series inte-
grins often mediate cell-matrix interaction. Integrins are a-13
heterodimeric transmembrane receptors whose specificity re-
flects the a- and 13-chains of the complex [7]. a1131 and a2j31
[8—11] bind collagens and laminin [12—14]. a3/31 may bind
laminin, collagen type I, fibronectin, entactin, epiligrin and the
a2/3l integrin [15—19]. a413l [20] and a5/3l [21] bind fibronectin.
a6131 and a7/31 bind laminin [22, 23].
Immunohistochemical studies show that MCs express inte-
grins in situ [24—26] and use multiple receptors to attach to the
same matrix component [24], but integrin expression, organi-
zation and the matrix partners involved have not been fully
characterized; there is still debate about exactly which integrins
are expressed in MCs and under what circumstances. There
have been few attempts to use molecular biological methods to
analyze integrins in MCs. The use of antibodies for identifying
integrins can be problematical as blocked epitopes, antibody
cross reactivity, lack of sensitivity and functional irrelevance
may all influence immunocytochemical analysis. In addition,
the amount of a given integrin on the cell may be constant, but
its function may change followng activation [7, 27, 28].
Thus, supporting non-immunologically based data are helpful
when probing for integrins. We have studied mRNA transcripts
of the integrin a-chains in MCs and integrins in focal adhesions,
morphologically well defined structures [29—31]. Neither
mRNA expression nor the focal contact distribution of integrins
in MCs has previously been examined. We cloned 131-series
integrin cDNAs from human and rat cells using polymerase
chain reaction (RT-PCR), and then employed them as probes in
Northern hybridization and in RT-PCR analysis of MCs. In
addition, we used RT-PCR to assess whether there was activa-
tion or inactivation of transcription of integrin messages in MCs
grown on different matrix substrates. Here we describe that al,
a2, a3, and aS integrin chains are transcribed in MCs and are
co-opted into focal adhesions. The transcription is not rapidly
altered as a short-term response to substrate.
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Fig. 1. Molecular cloning of integrin alpha
chains. (A) RT-PCR amplification of integrin
mRNA from Rugli and HT1O8O cells. Reverse
transcription of 5 ig of total RNA, 30 cycle
PCR reaction. Ten percent of the reaction
volume has been loaded on a 1% agarose gel
and the bands visualized with ethidium
bromide. 4X = 4Xl74 markers; al = al-
integrin primers on Rugli RNA; a2, a3, a4,
a5, a6 = a2-a6 integrin primers on HTIO8O
RNA. Marker sizes in base pairs are shown.
(B) Cloned integnn insert and partial
restriction maps. al-6 are integrin a-chains
from which clones were derived. Enzyme
digests of clones alternate with digests of their
inserts. PstI fragment a! cx pUC19 (pRIl.l);
BamHI-EcoRI fragment a2 ex pUCI8
(pHI2. 1); BamHI-EcoRI fragment a3 cx
pUC18 (pHI3. 1); fragment GkaS EcoRI
fragment a4 ex pUCI8 (pHI4.1). BamHI-
EcoRI fragment aS cx pUCl8 (pHI5. 1).
EcoRI fragment a6 ex pUCl8 (pHI6.l). 4X =
4Xl74 markers: AH = A-HindIII markers.
ApI = ApAI, E = EcoRl, B = BamHI, Ps =
PstI, Pv = PvuI, X = XhoI. (C) Partial
restriction maps of cloned inserts.
Methods
Unless otherwise stated, chemicals were of analytical grade
from Merck (Darmstadt) and biochemicals were from Sigma.
Tissue-culture-quality water was used throughout. Reagents for
polymerase chain reaction (PCR) and molecular cloning were
from Boehringer (Mannheim). Falcon tissue culture plastic was
from Becton-Djckenson. Tissue culture media and sera were
from Gibco-BRL.
Cell culture
Cell culture of HT1O8O (human fibrosarcoma), Rugli (rat
glioblastoma) and B 16 (mouse melanoma) cells have been
described elsewhere [11, 23, 32]. HT1O8O express VLA2,3,5
and 6. Rugli express the rat homologues of VLA-1,3,5 and
a7/31. B16 express the mouse homologues of VLA 2,5 and 6.
Preparation of MCs. Standard techniques were used [33, 34].
The cortex of rat kidneys was cut into fragments and pressed
through stainless steel sieves. Glomeruli retained between 105
jim and 75 jim sieves were gathered, washed and plated in D20
(DMEM, 20% heat-inactivated FCS, 2 m glutamate, 5 nglml
insulin, 100 U/ml penicillin, 1000 jig/ml streptomycin) at 3 X i04
glomeruli per 75 cm2 flask. MCs grew out from the glomeruli
within three to six weeks. After three to four passages, the
population was shifted to D10 (D20, but 10% in FCS). Human
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MC cultures from kidneys not suitable for transplantation were
prepared in a similar manner, but were maintained in RiO
[RPMI in place of DMEM, plus ITS (Boehringer; 10 sg ml)
and HEPES (15 mM; pH 7.3)]. MCs were withdrawn from the
cell cycle by incubation for 120 hours in D0.5 (D20, but 0.5%
FCS). Rat and human MCs showed positive staining for Thy!.1,
vascular smooth muscle cell myosin, actin and desmin, and had
characteristic morphology [33, 34]. The cultures showed uni-
form marker expression and no expression of MAC-i and factor
VIII, which are, respectively, markers for macrophages and
endothelial cells [34].
Molecular biological methods
Standard methods were used, where not otherwise detailed
[35].
Reverse transcription-polymerase chain reaction. PCR prim-
ers with minimal secondary structure or cross homology were
selected from integrin alpha-chain sequences (Rat al [36], and
human a2 [37], a3 [38], a4 [39], aS [40] and a6 [41]) and
synthesized with terminal recognition sites for the restriction
endonucleases BamHI, EcoRl, or PstI. The primers used were:
Rat al-up 5'CTACAAGATGGAGGATGGG 3' (bp. 1817-1835
+ PstI), Rat al-down S'GCCTCAGTGAATCAAGGG 3'(bp
2590-2607 + PstI); Hu a2-up 5'AGCTGGATCCACTCTGCT-
TCAGTGCAAAGTTCAGA 3 '(bp.2082-2 106 + BamHI), Hu
a2-down S'GTCAGAATITCAAAGTCCCGTTCCAAATFCTG-
GTAG 3' (bp. 3275-3299 + EcoRI); Hu a3-up 5'ATGCGAAT-
TCTGTGGTCAGGGTCAGAAGACG 3' (bp. 5 16-535 + EcoRI),
Hu a3-down 5' TCATGGATCCGGAGAAGAAGCCGTGG-
AAGACAGCG 3'(bp. 1681-1705 + BamHI); Hu a4-up
5 'GATCGGATCCGACGTGATTACAGGAAGCATACAGG
3'(bp.1666-l691 + BamHI), Hu a4-down5' TGACGAATTCGC-
AGTACAATAGCCTCTTATCAGTC 3' (bp. 2688-2713 + EcoRI)
[39]; Hu aS-up 5'TCAGGGATCCAACTTCAGCTGGACTG-
GCAGAAGCA 3'(bp.1657-l675 + BamHI) Hu aS-down
5 'GATCGAATTCGGGCATCTTCAGGGCTTTGTACACA
3'(bp.2900-2925 + EcoRl); Hu a6-up 5'TCAGGGATCCGTGT-
TGCCAACCAGAATGGCTCGC 3'(bp.2323-2346 + BamHI) Hu
a6-down 5 'GATCGAATTCCAGTCACTCGAACCTGAGT-
GCCTGC 3'(bp.3123-3l47 + EcoRI).
For the validation of the PCR primers, total RNA (1 to 5 p.g)
[42] from HT!080 or Rugli cells was transcribed (1 hr x 37°C)
with MMLV reverse transcriptase (200 U; Superscript, Strate-
gene) using integrin downstream primer (30 pmol) in a volume
of 20 d (75 mi KC1, 3 mi MgCI2, 50 m Tris Cl; pH 7.3). A
quarter of the reverse transcription mix was used for PCR (30
cycles; 35 seconds x 95°C, 30 seconds x 50°C, 150 seconds X
72°C) by adding dNTPs (20 nmol), up and downstream primers
(to 50 pmol) and Taq-polymerase (2.5 U; Stratagene) in 100 d
(50 mst KCI, 1.5 m MgCI2, 0.1% Triton X-iOO, 10 mri Tris-Cl;
pH 8.8). Amplified fragments were analyzed by electrophoresis
on agarose gels.
Cloning. cDNAs amplified by PCR were purified, cleaved
with restriction endonucleases (to generate PstI fragments for
rat-al and BamHI-EcoRI fragments for a2, a3, a4, aS and a6),
purified on agarose gels, and cloned into pUC18 or pUC19.
Inserts were analyzed by restriction mapping and by sequenc-
ing using the dideoxy method, which confirmed their identity
with the published sequences [36—41].
Northern hybridization analysis. Cloned integrin cDNA frag-
Fig. 2. Northern hybridization analysis of integrin expression in MCs.
Total RNA (30 sg) was run on 1% agarose-formaldehyde gels, trans-
ferred to nylon membranes and serially probed with radiolabeled
integrin inserts shown in Figure lB. HMC = human MCs, RMC = rat
MCs. All films were exposed for 72 hours. The nature of the probes
used is shown (al-a6).
ments were labeled with P32-ATP (Amersham) by random
priming (Gibco) to 1 X 108 dpm . rg'. Total RNA (30 g)
was resolved on agarose/formaldehyde gels, transferred to
nylon membranes (Hybond-N; Amersham) by capillary wick-
ing, and fixed by baking (2 hr x 80°C). After pre-hybridization
(2 hr x 38°C; 50% formamide, 5 x SSC, 0.5 x Denhardts
solution, 200 sg m1' herring sperm DNA, 1% SDS, 50 mM
phosphate buffer; pH 6.5) the membranes were hybridized with
the labeled cDNA probes (16 hr x 38°C). The membranes were
washed (38°C: 2 x 15 mm, 2 x SSC, 0.1% SDS; 2 x 30 mm, 0.2
x SSC, 0.1% SDS) and exposed to X-ray film (Kodak, XAR-5)
at —80°C. Filters were rehybridized following stripping in
boiling SDS (0.1%; 3 x 1 mm). Hybridization with gamma-actin
cDNA probes revealed comparable quantities of gamma-actin
message in each lane. The size of the hybridizing species was
estimated from the migration of the 28S and 18S rRNA [35].
Effect of substrate on inte grin gene expression
Human vitronectin [43], fibronectin [44], murine EHS-tumor
laminin [45] and human collagen type I (gift of Dr. K. von der
Mark, Max-Planck, Erlangen, Germany) were >95% pure by
SDS-PAGE. The proteins were dissolved in PBS (20 g ml')
and coated (1 hr x 37°C) on 6-well tissue culture plates
(Falcon). After blocking of free protein binding sites (2% heat
denatured BSA in PBS; 2 hr x 4°C), quiescent MCs were added
(5 X iO cells/well) in A-buffer (DMEM, 0.5% BSA, HEPES, 20
mM; pH 7.3). At six hours the cells were harvested, and total
cellular RNA was extracted [42]. Integrin cDNAs were ampli-
fied using RT-PCR (=40 cells °°i0 ng RNA per PCR) and the
products were resolved by agarose gel electrophoresis. Parallel
amplifications with RNA from HT1O8O and Rugli cells provided
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Fig. 3. Immunofluorescent labeling of
integrins in MCs. MCs were plated on (A, B)
collagen or (C, D) fibronectin for 4 hours
before fixation and labeling for (A) al, (B) a2,
(C) cr3, (D) a5 integrin chains. Rat MCs are
shown in A and human MCs in B through D.
Scale bar = 10 /.LM.
markers for the amplified products, which after Southern trans.
fer were confirmed by hybridization with the subcloned integrin
cDNAs.
Antibodies
Munne primary antibodies against human integnn alpha
chains P1E6 (cr2), P1B5 (cr3), and P1D6 (cr5) [15] and rabbit
anti-fibronectin were from Telios (La Jolla, California, USA).
Other antibodies were gifts of our colleagues: 7C7C7 (mouse
anti-human cr4; Dr. J. Cassiman and S. Vekemans, Leuven),
GOH3 (rat anti-mouse cr6 [46]), 3A3 (mouse anti-rat cr1 [9]),
AIIB2 mouse anti-1 integrin [10] and rabbit anti-talin [47].
Second layer fluorescent labeled antibodies were Texas-red
donkey-anti-mouse (Amersham) and Texas-red goat-anti-rat
(Dianova). Rabbit anti-collagen-I was the gift of Dr. K. von der
Mark (Erlangen) and rabbit anti-laminin was produced by
immunization with EHS-laminin. TRITC-phalloidin was from
Molecular Probes (Oregon)
Immunofluorescence
Immunofluorescence microscopy will be described elsewhere
(Note added in proof). Briefly, MCs were plated for four hours
in A-buffer on multichamber slides (Nunc) coated with matrix
protein (20 pg . mF' in PBS). After washing and fixation with
paraformaldehyde (3% wt/vol in PBS: 10 mm x 0°C), the cells
were permeabilized (Triton X-l00; 1% (wt/vol) in PBS; 10 mm
x 20°C), and incubated with primary antibody followed by
fluorescently labelled secondary antibody before mounting in
PVA (Moviol 4-88, pH 8.6; Hoechst). The cultures were exam-
ined under a Leitz Axioplan microscope equipped for epifluo-
rescence microscopy, and photographed at 3200 ASA on
TMAX film (Eastman-Kodak). Staining patterns qualitatively
as those described here developed as soon as the cells could be
fixed (0.5 to 1 hr) but were most extensive by four hours.
Cycloheximide treatment
Three hours before plating for immunofluorescence, cyclo-
heximide to a final concentration of 30 jsg m1' was added to
MC cultures. Subsequently, it was present in all solutions that
came into contact with the cells until they were fixed for
immunostaining. Endogenously produced matrix components
laminin, fibronectin and collagen type I were no longer detect-
able after this procedure (Note added in proof).
Results
Human and rat MCs transcribe inte grin message
RT-PCR was used to amplify mRNA transcripts from Rugli
(al) and HT1O8O cells (cr2-cr6). Integrin fragments of the pre-
dicted sizes (al, 790 bp; cr2, 1237 bp; cr3, 1209 bp; cr4, 1066 bp;
cr5, 1287 bp; cr6, 844 bp) could be amplified (Fig. la). When
cloned into pUC18 and pUC19 to generate unique cDNA
probes, the restriction maps (Fig. 1 b and c) and partial 2 to 300
bp sequences matched published integrin data (AP, HF and
SLG, unpublished observations).
The cloned integrin cDNAs were used to probe MCs using
Northern hybridization (Fig. 2). Integrin a! cDNA probes
yielded signals from both human and rat MCs, and from Rugli.
A strong signal was seen at 11.5 2 kb and a weak signal at 5.5
kb. Integrin a2 probes detected a signal only from HT1O8O cells,
at 9.0 2 kb. cr3 probes detected signals in human MCs and in
k&cct
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Fig. 4. Colocalisation of talin and integrins in
MCs. Human MCs were plated on fibronectin
and fixed and double labeled at 4 hours for
talin (a,b,c) or the integrins /31 (a'), a3 (b') or
a5 (c'). Arrowheads in (b,b') and (c,c')
indicate heterogeneous labeling of focal
contacts. Scale bar = 10 sM.
Rugli and HT1080, with a major signal at 5.5 kb and a minor
signal at 12 kb. Rat MCs and B16 expressed no a3. Only in
HT1O8O cells did the a4 probe detected a weak signal, at 6.5 kb.
The aS probe gave a signal at 5.0 kb, it was prominent in
MCs, strong in HT1O8O cells and weak in Rugli and B16. a6
probes gave signals only in HT1O8O, and weakly in B 16 and
Rugli at 7 kb. Weak bands in the HTIO8O lane were visible at
12 kb and 4.5 kb. Minor bands may represent mRNA
processing variants. The major bands migrated (within the
measurement errors) at similar rates to the integrin mRNAs
described in the literature [36—41].
MCs have inte grins in focal contacts on appropriate
substrates
MCs formed focal contacts on extracellular matrix (Fig. 3).
a1J31-containing focal contacts (FCs) formed in rat MCs on
collagen type I and laminin but not on fibronectin or vitronectin.
a2j31-containing FCs formed in human MCs on collagen, but
not on other substrates. On fibronectin, but not on collagen and
laminin, they formed a5/31-containing FCs. Surprisingly, a6/31
was not in FCs on any substrate. But a3/31 was in FCs on
collagen type I, laminin and fibronectin (Fig. 3). Double labeling
for the /31 integrin and talin showed precise co-distribution in
FCs (Fig. 4). In control cells, HT1O8O had a2f31 in FCs on
collagen, a5f31 in FCs on fibronectin, and a6f31 in FCs on
laminin, Rugli had al/31 in FCs on collagen and laminin. a3/31
was not in FCs.
Thus, al, a2, cr3, and aS integrin chains were in adhesive
complexes in MCs. The majority (>80%) of the MCs localized
integrins into talin-positive FCs as predicted from the integrin
specificities described by the literature. These data will be
discussed in detail elsewhere (Note added in proof).
MC cells can synthesize extracellular matrix. To test whether
focal contact formation was dependent on endogenously pro-
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Fig. 6. PCR analysis of inte grin expression in response to matrix
substrates. RNA from 8 x iO MCs or control cells (Rugli for rat
MCs; HT1O8O for human MCs) plated for 6 hours on the substrates
shown was amplified by RT-PCR using integrin specific-primers, the
reaction products were resolved on 1.5% agarose gels, transferred to
nitrocellulose and probed with labeled integrin inserts shown in Figure
1. Lanes are (1) MCs on serum; (2) MCs on fibronectin; (3) MCs on
vitronectin; (4) MCs on laminin; (5) MCs on collagen type I; (6) control
cells on serum. Rat MCs probed for a! were at a 0.5 hour exposure.
Human MCs probed for a2 were an 8 hour exposure, for a4 a 16 hour
exposure, for aS a 16 hour exposure, and for a6 were a 7 hour exposure.
Fig. 5. Inte grin and cytoskeleta! organization proceeds in the absence
of endogenous protein synthesis. MCs were preincubated for 3 hours
with 30 g m11 cycloheximide before trypsinization and 4 hours
attachment to collagen I in the continuous presence of cycloheximide,
before being fixed and double labeled for (A) alp! integrin and (B) actin
(phalloidin stain). Note the spread cells, the normal actin cytoskeleton
and the alp! integrin in focal contacts. Scale bar = 10 M.
duced proteins, protein synthesis was blocked by cyclohexi-
mide, and attachment and focal contact formation was studied.
Cell attachment and spreading, the construction of the actin-
talin cytoskeleton and the concentration of integrins into focal
contacts in a substrate-dependent manner were not affected by
cycloheximide (Fig. 5). Endogenous matrix production (judged
by immunofluorescence) was abolished (Note added in proof).
Growth on a particular matrix substrate does not cause rapid
switching of integrin expression in MCs
To increase the sensitivity of the mRNA analysis and to
assess whether substrate substantially affected integrin expres-
sion, quiescent MCs were plated onto matrix molecules and
integrin mRNA was amplified using PCR. The PCR products
were probed with the cloned integrin cDNAs to confirm the
identity of the amplified message (Fig. 6). Rat MCs expressed
al by RT-PCR. Human MC expressed very low levels of a2
message even after PCR amplification compared to HT1O8O. A
signal was seen using a3 primers in HMCs and HTIO8O, without
further probing (data not shown). There was no a4 signal from
MCs, while HT1O8O gave a strong signal. aS gave signals in
HT1O8O and MCs on all substrates. The second signal may
represent a minor splice variant form of a5 mRNA. Human MC
expressed very low levels of a6 message, even after PCR
amplification, compared to HT1O8O on all substrates.
In summary, the qualitative PCR analysis revealed integrin
al,2,3,5 and 6 mRNAs in MCs. Given the limitations of the
method, there was no evidence that the substrate caused a rapid
shut down or activation of integrin gene transcription.
Discussion
Integrins can mediate cell interaction with the extcacellular
matrix [7]. The regulation of integrin function may play a role in
the disease process, and this is of interest in glomerular
sclerosis and in other diseases where alteration of cell-matrix
interactions occurs [4—6]. A knowledge of integrin activity and
expression may suggest therapeutic or preventative ap-
proaches. Changes in mesangial cells and matrix are a hallmark
of progressive glomerular disease [4—6, 34], but little is known
about the regulation of integrin expression and activity in the
MC system. The matrix of MCs has been extensively investi-
gated [24-26], but the receptors they use to recognize it has not.
Integrins in tissue sections of kidney have been examined, but
only one study has considered MCs in culture [24]. Yet, there is
disagreement about which integrins are in MCs. Here, we have
used PCR amplification of integrin mRNA and immunofluores-
123456 123456
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cence microscopy to study integrins in cultured MCs. We find
that (a) MCs express mRNA for integrins al,2,3,5 and 6
mRNA; (b) that a! ,2,3 and 5 localize to focal contacts indepen-
dently of endogenous protein synthesis; and (c) there is no
rapid on/off switching of integrin mRNA in response to the
matrix.
The level of integrin a-chain mRNA reflects the potential
level of af3-complex at the cell surface [48, 49], while the
presence of integrins in focal contacts accompanies their usage
for attachment. We generated specific PCR primers and cDNA
probes for the integrin a-chains. The antibodies used have been
characterized elsewhere [11, 17, 23, 50, 51]. In Northern
analysis we detected al, a3 and a5, and by PCR a2 and a6 in
MCs. Immunofluorescence confirmed that all, a2J31, a33l
and a5f3l were present in focal contacts. a6/31 could not be seen
on the cell surface. The distribution pattern of integrins in focal
contacts was unaffected by blocking endogenous protein syn-
thesis, suggesting that the cells were responding to exogenous
rather than endogenous (that is, secreted) proteins. Indeed, it
was remarkable how little effect on attachment, spreading and
cytoskeletal organization this long blockade with cyclohexi-
mide had on cells. Similar observations on the lack of effect of
cycloheximide on spreading and focal contact formation have
recently been made [521.
al
MCs synthesize al [24-26], but in human MCs none was
found by immunostaining [24]. Here we find a! mRNA in
human MCs and rat MCs, and in rat MC focal contacts. al/31,
a potential collagen/laminin receptor, is present in cultured
MCs. The discrepancy in the literature may have arisen because
al/31 is only clearly visible in focal contacts, as when MCs are
on laminin or especially collagen, and not on vitronectin or
fibronectin (the substrates that form when cells are plated in
serum-containing medium). al/31 is characteristic of smooth
muscle cells in situ [53] and MCs have several features of
smooth muscle.
a2
a2/31 is in the mesangium on kidney sections [26], but it was
not found in cultured MCs [24]. On MCs we find very low levels
of a2 mRNA, while a2f31 protein is clearly found in focal
contacts on collagen. Although there is no strict relationship
between the level of a particular mRNA and the resulting
protein expression, the reason for the very low levels of a2
mRNA are far from clear. Perhaps a2 mRNA is very unstable,
although there have been no reports in the literature that would
support this. However, the result is probably correct. The MC
population is relatively clean judged by the homogenous stain-
ing with MC-specific markers (such as desmin) and for a2/3l
(that is, about 80% positive cells), and the defining anti-a2
antibody (P1E6) is highly specific. We have shown elsewhere
that the development of a2-containing focal contacts is highly
collagen dependent (Note added in proof) and that the defining
antibody only precipitates a2f3l from cells [23]. In MCs the
previous failure to find a2f31 may be due to the cells not having
been on collagen, only there is it highly concentrated and so
visible in focal contacts (as suggested for al above).
a3
There are two reports of a3f31 in MCs in tissue [24, 26], and
one in culture [24], while one group found little a3131 in tissue
[25]. We found that a3 mRNA was expressed in human MCs
and a3131 localized to focal contacts.
a4
a4 mRNA was not detected in MCs which agrees with
previous reports.
aS
There is one report of significant quantities of a5f3l in
glomerular tissue and as a fibronectin receptor in human MCs
[24]. We found aS is transcribed in human and rat MCs and it
localizes in focal contacts on fibronectin.
a6
RT-PCR but not Northern analysis or immunofluorescence of
MCs revealed a6. The very low levels of a6 transcript therefore
may represent non-regulated breakthrough transcripts.
It is of interest to establish whether the substrate regulates
the matrix receptors expressed at the cell surface. As integrin
proteins are long-lived [48], we investigated whether mRNA
levels were regulated in response to substrate. There was no
case where the message for a particular integrin was unequiv-
ocally shut off. We did not establish a quantitative PCR, which
might have been capable of detecting variations in mRNA
expression, but we could amplify five different integrins from
RNA derived from 8 x LO cells, and derived clear signals from
about 10 ng total RNA. In the future it will be highly interesting
to investigate whether integrin expression patterns vary when
mesangial cells are allowed to develop into three-dimensional
hillock cultures [6]. In numerous cellular systems, the switch
from two dimensional to three dimensional growth, and subse-
quent differentiation has a drastic influence on gene expression.
In summary, we combined mRNA and immunofluorescence
analysis to investigate integrin a-chains in cultured MCs.
a-chains a!, a2, a3 and aS detected in Northern hybridization
and PCR were found by immunofluorescence in focal adhe-
sions, suggesting that they may be involved in MC attachment.
Manipulation of integrin-MC interactions may suggest how they
are regulated and function and may lead to the development of
new diagnostic or therapeutic approaches in chronic inflamma-
tory disease of the glomeruli.
Note added in proof
Grenz, Carbonetto and Goodman; J Cell Sci (in press).
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